You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eculizumab

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Eculizumab
  • Beijing, China
  • +6 more
May 24, 2023

Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome Trial in Los Angeles,

Completed
  • Thrombotic Microangiopathies
  • +2 more
  • Eculizumab
  • Los Angeles, California
  • +2 more
Jan 17, 2023

Atypical Hemolytic Uremic Trial in China (Eculizumab)

Not yet recruiting
  • Atypical Hemolytic Uremic
  • Eculizumab
  • Beijing, China
  • +14 more
May 17, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)

Active, not recruiting
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Baltimore, Maryland
  • +4 more
Aug 15, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
    Regeneron Research Facility
Jan 28, 2022

Preeclampsia, Severe Preeclampsia, Eculizumab Trial in Los Angeles (Eculizumab)

Suspended
  • Preeclampsia
  • +11 more
  • Eculizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 16, 2022

Myasthenia Gravis, Myasthenia Gravis, Juvenile Form, Myasthenia Gravis, Generalized Trial in Japan, Netherlands, United States

Active, not recruiting
Has Results
  • Myasthenia Gravis
  • +2 more
  • Eculizumab
  • Los Angeles, California
  • +15 more
Aug 1, 2022

Guillain-Barre Syndrome Trial in Japan (Eculizumab, Placebo)

Completed
  • Guillain-Barre Syndrome
  • Eculizumab
  • Placebo
  • Bunkyo-ku, Japan
  • +25 more
Aug 26, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (ABP 959, Eculizumab)

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • ABP 959
  • Eculizumab
  • Atlanta, Georgia
  • +23 more
Nov 3, 2022

HELLP Syndrome (HELLP), Third Trimester, Complement Abnormality, Morbidity;Newborn Trial in Baltimore (Eculizumab)

Recruiting
  • HELLP Syndrome (HELLP), Third Trimester
  • +4 more
  • Eculizumab
  • Baltimore, Maryland
    The Johns Hopkins University
Jun 8, 2021

End Stage Liver Disease Trial in New Orleans (Eculizumab, No intervention)

Withdrawn
  • End Stage Liver Disease
  • Eculizumab
  • No intervention
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
Apr 5, 2021

Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles

Completed
Has Results
  • Antibody-mediated Rejection
  • +4 more
  • Eculizumab
  • Los Angeles, California
    Cedars Sinai Medical Center, Heart Institute
Apr 30, 2021

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Paris, France
  • +6 more
Dec 15, 2022

Antiphospholipid Antibody Syndrome, End Stage Renal Disease Trial in Baltimore (Eculizumab)

Completed
Has Results
  • Antiphospholipid Antibody Syndrome
  • End Stage Renal Disease
  • Eculizumab
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Oct 1, 2020

Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)

Recruiting
  • Kidney Transplantation in Highly Sensitized Patients
  • Birmingham, Alabama
  • +12 more
Jan 12, 2023

SARS-CoV-2, COVID19 Trial in Paris (Eculizumab)

Unknown status
  • SARS-CoV-2
  • COVID19
  • Eculizumab
  • Paris, Ile De France, France
  • +2 more
Apr 23, 2020

Coronavirus Trial (Eculizumab)

Available
  • Coronavirus
  • Eculizumab
  • (no location specified)
Mar 26, 2020

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Duarte, California
  • +39 more
Jan 13, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Eculizumab)

Completed
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria
  • Eculizumab
  • (no location specified)
Sep 13, 2019

Atypical Hemolytic Uremic Syndrome Trial in France (eculizumab)

Completed
  • Atypical Hemolytic Uremic Syndrome
  • eculizumab
  • Amiens, France
  • +21 more
Dec 5, 2019

Healthy Trial in Berlin (Eculizumab)

Completed
  • Healthy
  • Eculizumab
  • Berlin, Germany
    PAREXEL International GmbH, Early Phase Clinical Unit - Berlin
Jan 6, 2020

Kidney; Complications, Allograft Trial in New Haven (eculizumab)

Completed
Has Results
  • Kidney; Complications, Allograft
  • eculizumab
  • New Haven, Connecticut
    Yale University
Jul 2, 2019

Refractory Generalized Myasthenia Gravis Trial in Worldwide (Eculizumab, Placebo)

Completed
Has Results
  • Refractory Generalized Myasthenia Gravis
  • Eculizumab
  • Placebo
  • Birmingham, Alabama
  • +59 more
Jan 27, 2020

Delayed Function of Renal Transplant Trial in New York (Eculizumab, Placebo)

Terminated
  • Delayed Function of Renal Transplant
  • Eculizumab
  • Placebo
  • New York, New York
    Mount Sinai Recanati/Miller Transplantation Institute
May 2, 2019

Hemolytic Uremic Syndrome of Childhood Trial in France (Eculizumab, Placebo)

Completed
  • Hemolytic Uremic Syndrome of Childhood
  • Eculizumab
  • Placebo
  • Amiens, France
  • +17 more
Jul 11, 2019